Journal of Experimental & Clinical Cancer Research · 2018 · 26 citations · 22 references
MedicineHematologyOncologyChemotherapyMolecular OncologyStem Cell BiologyCancer Stem Cell BiologyCancer Stem Cell NicheCancer Stem CellsHematopoietic Stem Cell BiologyHematopoietic Stem CellsStem Cell NicheAcute Lymphoblastic Leukemia BiologyB-cell Acute Lymphoblastic LeukemiaBone Marrow Niche RegulationCancer Stem Cell NichesDifferentiationLeukemic NicheOncogenic Myc SignalingSelf-renewal
BACKGROUND: Considerable efforts have been devoted toward the uncovering of the molecular mechanisms underlying the maintenance of hematopoietic stem cells (HSCs) by the normal bone marrow (BM) niche. Previously, we demonstrated that a chemotherapy-induced niche, which is mainly composed of mesenchymal stem cells (MSCs), protects the residual B-cell acute lymphoblastic leukemia (B-ALL) cells from the insult of chemotherapeutic drugs. However, the roles of chemotherapy-induced niche on HSCs functions in B-ALL remain unclear. METHODS: We established an oncogenic N-MYC-driven B-ALL mouse model, which were subsequently treated with common chemotherapy drug cytarabine (Ara-C) and daunorubicin (DNR). After treatment, the structures of the BM niche were imaged by immunofluorescence staining. Then, the self-renewal and differentiation capability of the MSCs in the BM after Ara-C and DNR treatment were studied by ex vivo culture and gene expression analysis with RNA-seq and qRT-PCR. The effects of chemotherapy-induced niche on the hematopoietic reconstitution of HSCs were determined with series transplantation assay. Furthermore, the cell cycle, ROS level, mitochondrial membrane potential and cell apoptosis of HSCs were detected by flow cytometry. RESULTS: The MSCs, which is the main component of chemotherapy-induced BM niche, have decreased self-renewal capability and are prone to differentiate into adipocytes and chondrocytes. The results of gene expression analysis with RNA-seq showed that the MSCs have reduced levels of cytokines, including SCF, CXCL12, ANGPT1, VCAM1, and IL7. Furthermore, the chemotherapy-induced niche perturbed the hematopoietic reconstitution of HSCs in our N-MYC-driven B-ALL mouse model by promoting HSCs to enter cell cycle and increasing intracellular ROS levels and mitochondrial membrane potential of HSCs, which lead to the cell apoptosis of HSCs. CONCLUSIONS: Chemotherapy-induced BM niche perturbs the hematopoietic reconstitution of HSCs by increasing intracellular ROS level and inducing cell apoptosis.
22
Hematopoiesis: An Evolving Paradigm for Stem Cell Biology
Stuart H. Orkin, Leonard I. Zon · Cell · 2008 · 2.5K citations · Full text
Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche
Fumio Arai, Atsushi Hirao, Masako Ohmura et al. · Cell · 2004 · 1.9K citations · Full text
Anne Wilson, Elisa Laurenti, Gabriela Oser et al. · Cell · 2008 · 1.9K citations · Full text
CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance
Adam Greenbaum, Yen‐Michael S. Hsu, Ryan B. Day et al. · Nature · 2013 · 1.3K citations · Full text